Raffaella Zanardi, MD
- 6Articles
- 14.4KReads
- 1997–2005Active
- 9Collaborators
About
Raffaella Zanardi, MD, has contributed to research in psychiatry focusing on major depressive disorder (MDD) and its treatment. Her publications include clinical trials evaluating the efficacy of antidepressants such as escitalopram, sertraline, venlafaxine, fluvoxamine, citalopram, and paroxetine in preventing depressive recurrences and managing delusional depression. Zanardi's work spans from 1997 to 2005 and often involves double-blind, randomized controlled study designs. She has frequently collaborated with co-authors including Enrico Smeraldi, Linda Franchini, Jorge Perez, Mariangela Gasperini, and Alessandro Serretti.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
